Skip to content

Study on the Law of the Analgesic effect of Blood-letting Puncture on Spinal osteoartrosis

Study on the Law of the Analgesic effect of Blood-letting Puncture on Spinal osteoartrosis

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RPC-14005489
Enrollment
Unknown
Registered
2014-10-28
Start date
2014-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal osteoartrosis

Interventions

case series:Blood-letting Puncture therapy

Sponsors

Institute of Acupuncture and Moxibustion China Academy of Chinese Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. To be aged 18 to 70 years, male or female; 2. Accord with the standard of diagnosis of Cervical Spondylosis (the neck type or the nerve root type) or cervical disc herniation (the lateral type) or lumbar pain of strain or lumbar disc protrusion, the standard is on the Handbook of research; 3. With pain as chief complaint,VAS score are more than or equal to 4; 4. Accord with the TCM Syndrome type of the blood stasis pain, they are localized pain, twinge or dull pain, pain refused to press, pain aggravating at night and relieving in the day; 5. Patients volunteered to participate in this study, and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive dysfunction or mental disease patients; 2. Serious cardiovascular, cancer, liver and kidney organic diseases, hypopiesia patients; 3. Infected patients or blood disseminated diseases patients; 4. Severe lung and heart disease, anemia, hematologic diseases, blood coagulation dysfunction, poor wound healing, taking anticoagulant patients; 5. Spondylolisthesis, spinal stenosis, intervertebral disc extrusion or severe needing operation patients; 6. Pregnant patients.

Design outcomes

Primary

MeasureTime frame
VAS score;serum substance P;

Countries

China

Contacts

Public ContactWu Zhongchao
wutcm@sina.com+86 13693153329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026